ASGN Incorporated (NYSE:ASGN – Get Free Report) has been assigned a consensus rating of “Reduce” from the eight brokerages that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating on the company. The average 1-year target price among brokers that have covered the stock in the last year is $54.7143.
Several analysts have issued reports on the company. UBS Group dropped their price target on ASGN from $47.00 to $45.00 and set a “sell” rating on the stock in a research note on Thursday, October 23rd. Robert W. Baird set a $62.00 price target on ASGN in a research report on Thursday, February 5th. Weiss Ratings reiterated a “sell (d+)” rating on shares of ASGN in a report on Wednesday, January 21st. BMO Capital Markets reissued an “outperform” rating and issued a $65.00 price objective on shares of ASGN in a research report on Friday, February 6th. Finally, Wells Fargo & Company raised their target price on shares of ASGN from $49.00 to $54.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th.
View Our Latest Report on ASGN
ASGN Trading Down 13.9%
ASGN (NYSE:ASGN – Get Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The business services provider reported $1.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.18 by ($0.03). The business had revenue of $980.10 million during the quarter, compared to analyst estimates of $979.05 million. ASGN had a net margin of 2.85% and a return on equity of 10.94%. ASGN’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.28 earnings per share. ASGN has set its Q1 2026 guidance at 0.930-1.020 EPS. Sell-side analysts anticipate that ASGN will post 5.15 earnings per share for the current fiscal year.
Institutional Trading of ASGN
Several institutional investors and hedge funds have recently bought and sold shares of ASGN. Kennedy Capital Management LLC grew its stake in ASGN by 1.7% in the second quarter. Kennedy Capital Management LLC now owns 35,243 shares of the business services provider’s stock valued at $1,760,000 after purchasing an additional 594 shares in the last quarter. Congress Asset Management Co. acquired a new stake in shares of ASGN in the 3rd quarter valued at approximately $4,065,000. SG Americas Securities LLC lifted its stake in ASGN by 1,376.9% in the third quarter. SG Americas Securities LLC now owns 73,224 shares of the business services provider’s stock valued at $3,467,000 after acquiring an additional 68,266 shares during the last quarter. Reinhart Partners LLC. increased its stake in shares of ASGN by 5.2% during the 3rd quarter. Reinhart Partners LLC. now owns 1,072,427 shares of the business services provider’s stock worth $50,780,000 after purchasing an additional 53,021 shares during the last quarter. Finally, TradeLink Capital LLC bought a new stake in shares of ASGN in the 3rd quarter valued at about $259,000. Institutional investors own 95.36% of the company’s stock.
ASGN Company Profile
ASGN Incorporated (NYSE:ASGN) is a leading provider of specialized staffing and professional services, delivering tailored solutions across information technology, digital transformation, engineering and scientific disciplines. Through its diversified portfolio of brands, ASGN connects clients—ranging from life sciences and healthcare firms to technology enterprises and government agencies—with highly skilled consultants, project teams and permanent personnel. The company’s model emphasizes both temporary staffing and long-term consulting engagements to address complex talent and project needs.
ASGN’s service offerings are organized into two main business segments.
Featured Articles
- Five stocks we like better than ASGN
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Trump’s Hand-Written Letter Will Shock his Haters
- Trump’s national nightmare is here
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for ASGN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASGN and related companies with MarketBeat.com's FREE daily email newsletter.
